Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis: The PARADIGM Randomized Clinical Trial.
Saved in:
| Title: | Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis: The PARADIGM Randomized Clinical Trial. |
|---|---|
| Authors: | Cudkowicz M; Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Drory VE; Department of Neurology, Tel-Aviv Sourasky Medical Centre, Tel Aviv, Israel.; Gray Faculty of Medical and Health Science, Tel Aviv University, Tel Aviv, Israel., Chio A; Rita Levi Montalcini Department of Neuroscience, University of Torino and Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy., Lunetta C; Istituti Clinici Scientifici Maugeri IRCCS, Neurorehabilitation Department, Milan, Italy., Shoesmith C; Department of Clinical Neurological Sciences, Division of Neurology, London Health Sciences Centre, London, Ontario, Canada., van Eijk RPA; Department of Neurology and Biostatistics, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands., Salomon-Zimri S; NeuroSense Therapeutics, Herzliya, Israel., Shtossel D; NeuroSense Therapeutics, Herzliya, Israel., Kerem N; NeuroSense Therapeutics, Herzliya, Israel., Shapira G; Gray Faculty of Medical and Health Science, Tel Aviv University, Tel Aviv, Israel., Shomron N; Gray Faculty of Medical and Health Science, Tel Aviv University, Tel Aviv, Israel., Russek-Blum N; NeuroSense Therapeutics, Herzliya, Israel., Tracik F; NeuroSense Therapeutics, Ulm, Germany., Rosenfeld J; Department of Neurology, Loma Linda University School of Medicine, Loma Linda, California., Shefner J; Department of Neurology, Barrow Neurological Institute, Phoenix, Arizona. |
| Source: | JAMA neurology [JAMA Neurol] 2026 May 01; Vol. 83 (5), pp. 471-480. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print Cited Medium: Internet ISSN: 2168-6157 (Electronic) Linking ISSN: 21686149 NLM ISO Abbreviation: JAMA Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41837970 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis: The PARADIGM Randomized Clinical Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cudkowicz+M%22">Cudkowicz M</searchLink>; Healey & AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Drory+VE%22">Drory VE</searchLink>; Department of Neurology, Tel-Aviv Sourasky Medical Centre, Tel Aviv, Israel.; Gray Faculty of Medical and Health Science, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Chio+A%22">Chio A</searchLink>; Rita Levi Montalcini Department of Neuroscience, University of Torino and Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Lunetta+C%22">Lunetta C</searchLink>; Istituti Clinici Scientifici Maugeri IRCCS, Neurorehabilitation Department, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Shoesmith+C%22">Shoesmith C</searchLink>; Department of Clinical Neurological Sciences, Division of Neurology, London Health Sciences Centre, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22van+Eijk+RPA%22">van Eijk RPA</searchLink>; Department of Neurology and Biostatistics, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Salomon-Zimri+S%22">Salomon-Zimri S</searchLink>; NeuroSense Therapeutics, Herzliya, Israel.<br /><searchLink fieldCode="AU" term="%22Shtossel+D%22">Shtossel D</searchLink>; NeuroSense Therapeutics, Herzliya, Israel.<br /><searchLink fieldCode="AU" term="%22Kerem+N%22">Kerem N</searchLink>; NeuroSense Therapeutics, Herzliya, Israel.<br /><searchLink fieldCode="AU" term="%22Shapira+G%22">Shapira G</searchLink>; Gray Faculty of Medical and Health Science, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Shomron+N%22">Shomron N</searchLink>; Gray Faculty of Medical and Health Science, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Russek-Blum+N%22">Russek-Blum N</searchLink>; NeuroSense Therapeutics, Herzliya, Israel.<br /><searchLink fieldCode="AU" term="%22Tracik+F%22">Tracik F</searchLink>; NeuroSense Therapeutics, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Rosenfeld+J%22">Rosenfeld J</searchLink>; Department of Neurology, Loma Linda University School of Medicine, Loma Linda, California.<br /><searchLink fieldCode="AU" term="%22Shefner+J%22">Shefner J</searchLink>; Department of Neurology, Barrow Neurological Institute, Phoenix, Arizona. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101589536%22">JAMA neurology</searchLink> [JAMA Neurol] 2026 May 01; Vol. 83 (5), pp. 471-480. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101589536 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2168-6157 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221686149%22">21686149 </searchLink><i>NLM ISO Abbreviation: </i>JAMA Neurol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41837970 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1001/jamaneurol.2026.0230 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 471 Titles: – TitleFull: Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis: The PARADIGM Randomized Clinical Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cudkowicz M – PersonEntity: Name: NameFull: Drory VE – PersonEntity: Name: NameFull: Chio A – PersonEntity: Name: NameFull: Lunetta C – PersonEntity: Name: NameFull: Shoesmith C – PersonEntity: Name: NameFull: van Eijk RPA – PersonEntity: Name: NameFull: Salomon-Zimri S – PersonEntity: Name: NameFull: Shtossel D – PersonEntity: Name: NameFull: Kerem N – PersonEntity: Name: NameFull: Shapira G – PersonEntity: Name: NameFull: Shomron N – PersonEntity: Name: NameFull: Russek-Blum N – PersonEntity: Name: NameFull: Tracik F – PersonEntity: Name: NameFull: Rosenfeld J – PersonEntity: Name: NameFull: Shefner J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2168-6157 Numbering: – Type: volume Value: 83 – Type: issue Value: 5 Titles: – TitleFull: JAMA neurology Type: main |
| ResultId | 1 |